期刊文献+

白细胞计数与甲状腺未分化癌预后负相关原因初探 被引量:2

Preliminary Research on Negative Correlation between White Blood Cell Count and Prognosis of Anaplastic Thyroid Cancer
下载PDF
导出
摘要 目的探讨甲状腺未分化癌(ATC)患者白细胞(WBC)计数与预后负相关的原因.方法回顾性分析云南省肿瘤医院20 a间收治的42例ATC患者的临床及随访资料,采用免疫组化的方法检测存档ATC蜡块中CSF1、EPO、IL-6和IL-11表达水平,探索其表达水平与ATC患者预后及WBC计数的关系.结果 42例ATC组织中CSF1、EPO、IL-6和IL-11阳性率分别为69.0%、69.0%、83.3%和71.4%;CSF1和IL-11表达水平与ATC患者预后负相关、与WBC计数正相关(P<0.05),而EPO和IL-6与患者预后及WBC计数均无相关性(P>0.05).结论 WBC计数是ATC患者负相关因素,可能与ATC细胞分泌CSF1和IL-11有关,其机制值得进一步深入研究. Objective To explore the reason of the negative correlation of white blood cell (WBC) count with the prognosis of patients with anapIastic thyroid carcinoma (ATC) . Methods Clinical and follow-up data of 42 ATC patients at our hospital were analyzed retrospectively. The expressions of CSF1, EPO, IL-6 and IL-11 in specimens of these patients were evaluated by immunohistochemistry, and the relationships with the prognosis and WBC count of ATC patients were investigated. Results The positive rates of CSF1, EPO, IL-6 and IL-11 were 69%, 69%, 83.3% and 71.4%, respectively. The expressions of CSF1 and IL-11 were positively correlated to WBC count and negatively correlated to the prognosis of ATC patients, but the expressions of EPO and IL-6 were neither correlated to the prognosis nor to the WBC count. Conclusion The negative correlation between WBC count and the prognosis of ATC patients may be related to the secretions of CSF1 and IL-11 of ATC cells, but its exact mechanism deserved to be researched in the future.
出处 《昆明医科大学学报》 CAS 2015年第9期27-31,共5页 Journal of Kunming Medical University
基金 国家自然科学基金资助项目(81260402) 云南省高层次卫生技术人员专项经费基金资助项目(D-201243)
关键词 甲状腺未分化癌 白细胞计数 集落刺激因子 促红细胞生成素 白细胞介素 Anaplastie thyroid carcinoma White blood cell CSF1 EPO Interleukin
  • 相关文献

参考文献3

二级参考文献50

  • 1孙传政,陈福进,曾宗渊,陈艳峰,李秋梨,关中,田慎之.甲状腺未分化癌的治疗和预后[J].中华外科杂志,2006,44(21):1493-1497. 被引量:14
  • 2Albores-Saavedra J, Henson DE, Glazer E, et al. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study. Endoer Pathol,2007,18 : 1-7.
  • 3GoutsouliakV,HayJH. Anaplastic thyroid cancer in British Columbia 1985-1999 : a population-based study. Clin 0ncol,2005, 17:75-78.
  • 4Kebebew E,Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer, 2005,103 : 1330-1335.
  • 5Pierie JP, Muzikansky A, Gaz RD, et al. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol,2002,9:57-64.
  • 6Passler C,Scheuba C, Prager G, et al. Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg, 1999,384:284-293.
  • 7Giuffrida D,Gharib H.- Anapiastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol2000,11 : 1083-1089.
  • 8Bravo SB, Garcia-RenduelesME, Seoane R, et al. Plitidepsin has a cytostatic effect in human undifferentiated ( anaplastic ) thyroid carcinoma. Clin Cancer Res,2005,11:7664-7673.
  • 9Ito Y, Motoo Y, Yoshida H, et al. High level of tumour protein p53- induced nuclear protein 1 ( TP531NP1 ) expression in anaplastic carcinoma of the thyroid. Pathology,2006,38:545-547.
  • 10Wang HM, Huang YW, Huang JS, et al. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma. Ann Surg Oncol,2007 ,14 :3011-3018.

共引文献19

同被引文献35

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部